Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study

Hassany M.; Albreedy A.; Rahman T. A.; Eysa B.; Aziz H. A.; Asem N.; Ibrahem M.; Esmat G.

首页> 外文期刊>Journal of viral hepatitis. >Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study

【24h】

Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study

机译：直接代理抗病毒药于基因型4慢性丙型肝炎老年患者的安全性和有效性，试点研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2018年第s2期|共2页
作者
Hassany M.; Albreedy A.; Rahman T. A.; Eysa B.; Aziz H. A.; Asem N.; Ibrahem M.; Esmat G.;
展开▼
作者单位

Natl Hepatol &

Trop Med Res Inst Trop Med Dept Cairo Egypt;

Ain Shams Univ Trop Med Dept Cairo Egypt;

Ain Shams Univ Trop Med Dept Cairo Egypt;

Natl Hepatol &

Trop Med Res Inst Trop Med Dept Cairo Egypt;

Natl Hepatol &

Trop Med Res Inst Cairo Egypt;

Dept Publ Hlth &

Community Med Cairo Egypt;

Dept Clin Biochem Cairo Egypt;

Cairo Univ Endem Med Dept Cairo Egypt;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China [J] . Xiaozhong Wang, Lai Wei 临床与转化肝病杂志（英文版） . 2021,第003期
2. Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors [J] . Karn Wijarnpreecha, Supavit Chesdachai, Charat Thongprayoon, 临床与转化肝病杂志（英文版） . 2017,第004期
3. P1‐107: Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P1-107：直接代理抗病毒药在基因型4慢性丙型肝炎老年患者的安全性和有效性，试点研究
4. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis (vol 51, pg 741, 2016) [J] . Toyoda Hidenori, Kumada Takashi, Tada Toshifumi, Journal of gastroenterology . 2016,第7期

机译：血液透析患者使用双重直接作用抗病毒治疗（达卡他韦和阿舒那韦）对慢性丙型肝炎病毒基因型1感染的安全性和有效性（第51卷，第741页，2016年）
5. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis [J] . Toyoda Hidenori, Kumada Takashi, Tada Toshifumi, Journal of gastroenterology . 2016,第7期

机译：血液透析患者双重直接作用抗病毒治疗（达卡他韦和阿舒那韦）对慢性丙型肝炎病毒基因型1感染的安全性和有效性
6. Genotype and Serotype Identification of Hepatitis B Virus in Chronic Hepatitis B Patients Treated with Telbivudine [C] . Y Purnamasari, Tien, Arimaswati, International Seminar on Smart Molecule of Natural Resources . 2020

机译：临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
7. Clinical and economic outcomes of direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid. [D] . Pham, Timothy Tung. 2016

机译：直接作用抗病毒药在俄克拉荷马州医疗补助中的慢性丙型肝炎感染的临床和经济结果。
8. Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6 [O] . Ong The Due, Usa Chaikledkaew, Anne Julienne M. Genuino, 2019

机译：具有Meta分析的系统评价：慢性丙型肝炎基因型5和6的直接作用抗病毒的疗效和安全性
9. Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis [O] . Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, 2016

机译：误解：双直效抗病毒治疗的安全性和有效性（Daclatasvir和Asunaprevir）用于血液透析患者慢性丙型肝炎病毒基因型1感染
10. Guidance for Industry Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment [R] . 2010

机译：工业慢性丙型肝炎病毒感染指南：开发直接作用的抗病毒药物进行治疗

Safety and efficacy of direct acting antivirals in genotype 4 chronic hepatitis C elderly patients, a pilot study

著录项

相似文献

相关主题

期刊订阅